25 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35450077 | The Nutritional Intervention of Resveratrol Can Effectively Alleviate the Intestinal Inflammation Associated With Celiac Disease Induced by Wheat Gluten. | 2022 | 2 |
2 | 35546166 | Resveratrol blocks retrotransposition of LINE-1 through PPAR α and sirtuin-6. | 2022 May 11 | 1 |
3 | 33580595 | The effects of resveratrol supplementation on PPARα, p16, p53, p21 gene expressions, and sCD163/sTWEAK ratio in patients with type 2 diabetes mellitus: A double-blind controlled randomized trial. | 2021 Jun | 2 |
4 | 34552688 | Lipidomic Alterations and PPARα Activation Induced by Resveratrol Lead to Reduction in Lesion Size in Endometriosis Models. | 2021 | 1 |
5 | 31173696 | Resveratrol protects against nonalcoholic fatty liver disease by improving lipid metabolism and redox homeostasis via the PPARα pathway. | 2020 Mar | 6 |
6 | 32170654 | Effects of resveratrol and its derivative pterostilbene on brown adipose tissue thermogenic activation and on white adipose tissue browning process. | 2020 May | 2 |
7 | 33224240 | Resveratrol Reduces Lipid Accumulation through Upregulating the Expression of MicroRNAs Regulating Fatty Acid Bet Oxidation in Liver Cells: Evidence from In-vivo and In-vitro Studies. | 2020 Spring | 1 |
8 | 30674874 | PPARα and PPARγ activation attenuates total free fatty acid and triglyceride accumulation in macrophages via the inhibition of Fatp1 expression. | 2019 Jan 15 | 2 |
9 | 30867708 | Resveratrol suppresses proliferation and induces apoptosis of uterine sarcoma cells by inhibiting the Wnt signaling pathway. | 2019 Mar | 2 |
10 | 30995737 | Nuclear Peroxisome Proliferator-Activated Receptors (PPARs) as Therapeutic Targets of Resveratrol for Autism Spectrum Disorder. | 2019 Apr 16 | 1 |
11 | 31278094 | The effect of resveratrol supplementation on the expression levels of factors associated with cellular senescence and sCD163/sTWEAK ratio in patients with type 2 diabetes mellitus: study protocol for a double-blind controlled randomised clinical trial. | 2019 Jul 4 | 1 |
12 | 26968898 | Cooperative action of bioactive components in milk fat with PPARs may explain its anti-diabetogenic properties. | 2016 Apr | 1 |
13 | 27098390 | Resveratrol enhances HBV replication through activating Sirt1-PGC-1α-PPARα pathway. | 2016 Apr 21 | 3 |
14 | 25772176 | Resveratrol Targets in Inflammation. | 2015 | 3 |
15 | 24309288 | Resveratrol protects RPE cells from sodium iodate by modulating PPARα and PPARδ. | 2014 Jan | 3 |
16 | 24584901 | Inhibitory effects of resveratrol on foam cell formation are mediated through monocyte chemotactic protein-1 and lipid metabolism-related proteins. | 2014 May | 5 |
17 | 24606795 | Mitochondrial biogenesis: pharmacological approaches. | 2014 | 1 |
18 | 24796862 | Resveratrol and its metabolites bind to PPARs. | 2014 May 26 | 11 |
19 | 21791144 | Repeated and long-term treatment with physiological concentrations of resveratrol promotes NO production in vascular endothelial cells. | 2012 Mar | 1 |
20 | 22382311 | Recent advances in the study on resveratrol. | 2012 | 2 |
21 | 20372816 | Resveratrol prevents the impairment of advanced glycosylation end products (AGE) on macrophage lipid homeostasis by suppressing the receptor for AGE via peroxisome proliferator-activated receptor gamma activation. | 2010 May | 3 |
22 | 20973122 | Pan-PPAR agonists based on the resveratrol scaffold: biological evaluation and docking studies. | 2010 Dec 3 | 1 |
23 | 21113404 | Peroxisome Proliferator-Activated Receptor -β/δ, -γ Agonists and Resveratrol Modulate Hypoxia Induced Changes in Nuclear Receptor Activators of Muscle Oxidative Metabolism. | 2010 | 1 |
24 | 19135132 | Resveratrol inhibits MMP-9 expression by up-regulating PPAR alpha expression in an oxygen glucose deprivation-exposed neuron model. | 2009 Feb 20 | 1 |
25 | 17134953 | The dietary antioxidant resveratrol affects redox changes of PPARalpha activity. | 2007 May | 1 |